Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001209191-24-003241 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-13 | 2024-02-09 | RXRX | Mauro David J | Chief Medical Off | A - Grant | $0.00 | +55.8K | 196.8K | +40% | $0 |
| D | 2024-02-13 | 2024-02-09 | RXRX | Mauro David J | Chief Medical Off | F - Tax | $10.09 | -1,892 | 244.6K | -0.8% | -$19.1K |
| D | 2024-02-13 | 2024-02-09 | RXRX | Mauro David J | Chief Medical Off | A - Grant | $0.00 | +99.5K | 99.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-09 | A | A | 49,768 | $0.00 | 246,521 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-02-09 | A | A | 6,040 | $0.00 | 196,753 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-02-09 | F | D | 1,892 | $10.09 | 244,629 | D | — | — | |
| 4 | Derivative | Stock Option (RIght to Buy) | 2024-02-09 | A | A | 99,537 | $0.00 | 99,537 | D | $10.09 · — to 2034-02-09 | 99,537 Class A Common Stock | (F5) The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. |